Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're looking into weight loss injections from Newry, the two medicines available in the UK are tirzepatide (Mounjaro) and semaglutide (Wegovy). Both are once-weekly subcutaneous injections licensed for weight management in adults who meet clinical criteria. They require a prescription following a proper clinical assessment — a prescriber decides suitability, not a website. The decision that matters most isn't which pharmacy charges least; it's whether this treatment is right for you, at the right dose, with the right support around it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching from Newry aren't asking a pharmacology question. They're asking: is this treatment something I can actually access, will it work for my situation, and can I trust the route I take to get it? Those are exactly the right questions. A weight loss injection is a prescription-only medicine under UK law, which means no clinical assessment, no prescription. What that means in practice is that a qualified prescriber reviews your health history, current medicines, and BMI before anything is dispensed.
The broader picture on weight loss injections covers both medicines in detail, but the short answer for Newry residents is that geography matters less than you might think. A GPhC-registered online pharmacy can serve patients across the UK, including Northern Ireland, with the same clinical rigour as any high-street service, and with free next-working-day tracked delivery to your door.
One misconception worth putting to rest gently: that these medicines are only for people with severe obesity. The licensed BMI threshold is 30 or above, or 27 and above if you have at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. The prescriber looks at the full picture. A number alone never decides the outcome.
Both medicines slow gastric emptying and act on the brain's appetite centres, reducing hunger between meals and increasing the sense of fullness after eating. Tirzepatide does this through two receptor pathways; semaglutide through one. In clinical trials, tirzepatide produced greater average weight loss, a finding confirmed in the head-to-head SURMOUNT-5 trial published in the New England Journal of Medicine in 2025. But a trial average isn't a personal prediction, individual responses vary, and the prescriber's job includes monitoring progress over time.
The gradual dose escalation schedule is there to let your digestive system adjust. The starting dose is a tolerability measure; its job is to settle the body before the therapeutic dose is reached. Skipping steps or escalating too quickly significantly increases the chance of nausea, vomiting and dizziness. This is one reason that clinical oversight matters throughout treatment, not just at the point of prescription.
If you want to understand recent approvals and what's changed in this space, the latest news on weight loss injections covers MHRA updates and new developments as they happen. There are now 3 weight loss injections available in licensed formats, and if you're curious about what has come to market most recently, the new weight loss injection page explains options that didn't exist 18 months ago.
The most common side effects are gastrointestinal: nausea, diarrhoea, constipation, indigestion and burping. These tend to peak in the days after starting or after a dose increase, and many people find they settle within a week or two. Injection-site reactions, headache, fatigue and dizziness are also reported. The NHS's patient-level guidance on tirzepatide lists the full side-effect profile with plain-English explanations.
Two situations warrant prompt medical attention. Severe, persistent stomach pain that spreads to the back (with or without vomiting) may indicate pancreatitis, which is rare but serious. The MHRA highlighted this in a January 2026 Drug Safety Update covering GLP-1 medicines. Separately, any signs of a serious allergic reaction need emergency care. The Yellow Card scheme at yellowcard.mhra.gov.uk is the right place to report any suspected side effect.
People who are pregnant, trying to conceive, or breastfeeding should not use these medicines. Neither is licensed for under-18s. Women using oral contraceptives who are prescribed tirzepatide specifically should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because GI slowing may affect pill absorption. Your prescriber will discuss this at consultation.
For Newry residents, the NHS route to these medicines exists but is phased and criteria-restricted. Tirzepatide under NICE TA1026 is currently available through GP practices for those with a BMI of 40 or above and four or more specific weight-related conditions. Wegovy through specialist weight management services under NICE TA875 carries waiting lists that can run to months. Private treatment through a regulated online pharmacy is the alternative for people who meet the licensed criteria but don't qualify for NHS access yet, or who prefer not to wait.
When assessing any provider, check their GPhC registration, the register is publicly searchable at pharmacyregulation.org/registers. A legitimate service will require a full clinical assessment before prescribing, verify your identity and weight, and not offer these medicines to anyone who asks. If a seller offers weight loss injections without asking for a prescription or health history, that is a red flag. The MHRA has seized large quantities of counterfeit weight loss pens in recent years, some containing dangerous substances.
For a clear view of what private treatment typically costs and what should be included in the price, the guide to weight loss injection prices breaks down what a legitimate quote covers and what to watch for when comparing providers. At nume, one transparent price covers consultation, prescription, treatment and free next-working-day delivery, no subscriptions, no hidden fees. Our clinical team reviews every consultation personally. If you'd like to explore whether treatment is right for you, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.